Keimyung University Dongsan Medical Center
Daegu, Korea, Republic of
University in Daegu
1035 Dalgubeol-daero, Sindang-dong, Dalseo-gu, Daegu
About Keimyung University Dongsan Medical Center
Keimyung University, abbreviated as KMU or Keimyung, is a private university located in Daegu, the fourth largest city in South Korea. The university takes roots from Jejungwon founded in 1899.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Keimyung University Dongsan Medical Center
During the past decade, Keimyung University Dongsan Medical Center conducted 199 clinical trials. In the 10-year time frame, 199 clinical trials started and 49 clinical trials were completed, i.e. on
average, 24.6% percent of trials that started reached the finish line to date. In the past 5 years, 60 clinical trials started and 30 clinical trials were completed. i.e. 50%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
1 Year Trial Telmisartan 80 mg Versus Valsartan 160 mg in Hypertensive Type 2 Diabetic Patients With Overt Nephropathy
2003-04-01
2005-12-01
Completed
885
A Prospective, Randomised, Double-blind, Double-dummy, Forced-titration, Multicentre, Parallel Group, One Year Treatment Trial to Compare Telmisartan (MICARDIS) 80 mg Versus Losartan (COZAAR) 100 mg, in Hypertensive Type 2 Diabetic Patients With Overt Nephropathy (AMADEO Study)
2003-07-01
Completed
860
Vision Testing in Patients With Partial Seizures Receiving Either Lyrica or Placebo
2006-07-26
2020-02-04
Completed
187
Zotarolimus-Eluting Stent Versus Sirolimus-Eluting Stent and PacliTaxel-Eluting Stent for Coronary Lesions
2006-10-01
2009-01-01
Completed
2,645
Post Marketing Surveillance Study To Observe Safety And Efficacy Of Sutene
2007-05-01
2015-03-01
Completed
520
Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
2007-12-06
Active, not recruiting
1,052
Clopidogrel Use and Long-term Safety After Drug-Eluting Stents Implantation
2007-10-01
2010-04-01
Completed
1,175
Post Marketing Surveillance Study To Observe Safety And Efficacy Of Eraxis® IV
2012-03-02
2016-05-20
Completed
244
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Keimyung University Dongsan Medical Center" #1 sponsor was "Seung-Jung Park" with 33 trials, followed by "Keimyung University Dongsan Medical Center" with 16 trials
sponsored, "Pfizer" with 15 trials sponsored, "Hoffmann-La Roche" with 14 trials sponsored and "Boehringer Ingelheim"
with 14 trials sponsored. Other sponsors include 217 different institutions and
companies that sponsored additional 115 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Keimyung University Dongsan Medical Center"
#1 collaborator was "CardioVascular Research Foundation, Korea" with 41 trials as a collaborator, "Seoul National University Hospital" with 13 trials as a collaborator, "Keimyung University Dongsan Medical Center" with 11 trials as a collaborator, "Ulsan University Hospital" with 10 trials as a collaborator and "Inje University" with 8 trials as a collaborator. Other collaborators include 243 different institutions and companies that were
collaborators in the rest 181 trials.
Clinical Trials Conditions at Keimyung University Dongsan Medical Center
According to Clinical.Site data, the most researched conditions in "Keimyung University Dongsan Medical Center" are
"Coronary Artery Disease" (40 trials), "Atrial Fibrillation" (15 trials), "Gastric Cancer" (11 trials), "Coronary Disease" (9 trials) and "Hypertension" (7 trials). Many other conditions were trialed in "Keimyung University Dongsan Medical Center" in a lesser frequency.
Clinical Trials Intervention Types at Keimyung University Dongsan Medical Center
Most popular intervention types in "Keimyung University Dongsan Medical Center" are "Drug" (184 trials), "Device" (49 trials), "Other" (28 trials), "Procedure" (25 trials) and "Biological" (22 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (28 trials), "Paclitaxel" (8 trials), "Carboplatin" (6 trials), "Cisplatin" (5 trials) and "Quality-of-Life Assessment" (5 trials). Other intervention names were less common.
Clinical Trials Genders at Keimyung University Dongsan Medical Center
The vast majority of trials in "Keimyung University Dongsan Medical Center" are
278 trials for "All" genders, 23 trials for "Female" genders and 7 trials for "Male" genders.
Clinical Trials Status at Keimyung University Dongsan Medical Center
Currently, there are NaN active trials in "Keimyung University Dongsan Medical Center".
1 are not yet recruiting,
66 are recruiting,
43 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 133 completed trials in Keimyung University Dongsan Medical Center,
undefined suspended trials,
and 22 terminated clinical trials to date.
Out of the total trials that were conducted in Keimyung University Dongsan Medical Center, 13 "Phase 1"
clinical trials were conducted, 54 "Phase 2" clinical
trials and 83 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 50 trials, and there were
also 36 trials that are defined as “Not Applicable".